Rosemina Merchant

A Prostate-Specific Antigen-Activated Channel-Forming Toxin as Therapy for Prostatic Disease

Sarah Williams, Rosemina Merchant, Elizabeth Garrett‐Mayer et al. · JNCI Journal of the National Cancer Institute · 2007 · 89 citations · Full text

Medicine, Molecular Biology, Oncology +12

Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia

Mostafa Elhilali, Peter Pommerville, Richard C. Yocum et al. · The Journal of Urology · 2012 · 61 citations

Medicine, Pharmacotherapy, Urology +13

Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

Samuel R. Denmeade, Blair Egerdie, Gary Steinhoff et al. · European Urology · 2010 · 61 citations

Medicine, Surgery, Urology +10

Optimization of fermentation conditions for thermostable cellulase production byThielavia terrestris

Argyrios Margaritis, Rosemina Merchant · Journal of Industrial Microbiology & Biotechnology · 1986 · 20 citations · Full text

Life Sciences, Bioengineering, Biotechnology +14

Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity

Ravibhushan Singh, Jeffrey L. Browning, Ralph J. Abi‐Habib et al. · Anti-Cancer Drugs · 2007 · 14 citations

Life Sciences, Biochemistry, Molecular Biology +11